4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-003132
Options or other derivatives
- Chief Executive Officer acquired 3,988,560 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rawcliffe Adrian Chief Executive Officer | 2021-01-11 | Grant or award · Option to purchase Ordinary Shares | +3,260,400 | 3,260,400 | D | ||
| Rawcliffe Adrian Chief Executive Officer | 2021-01-11 | Grant or award · Option to purchase Ordinary Shares | +728,160 | 728,160 | D | ||
Loading xslF345X03/tm212800-4_4seq1.xml…